Research Focus

Former Employee. Physician in Chief; IRB Associate

Recent additions – View all

1. Phase I, open-label, dose-escalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liver

   Journal Article

   Kemeny, N.; Brown, K.; Covey, A.; Kim, T.; Bhargava, A.; Brody, L.; Guilfoyle, B.; Haag, N. P.; Karrasch, M.; Glasschroeder, B.; more...
   Human Gene Therapy (2006)

   Fulltext@MSK | Save
2. Results of a phase I, dose-escalating study of the safety, tolerability and anti-tumor activity of a single injection of a genetically engineered herpes simplex virus, NV1020, in subjects with hepatic colorectal metastases

   Meeting Abstract

   Kemeny, N.; Jarnagin, W.; Guilfoyle, B.; Tufaro, F.; Karrasch, M.; Mescheder, A.; Ries, S.; Haag, N.; Fong, Y.
   Annals of Oncology (2005)

   Fulltext@MSK | Save